|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 USD | -15.84% |
|
0.00% | -43.30% |
| 2023 | Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2022 | Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 | CI |
Remedent, Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was EUR 0.046112 million compared to EUR 0.401905 million a year ago. Revenue was EUR 0.413933 million compared to EUR 0.774611 million a year ago.
Net loss was EUR 0.304133 million compared to net income of EUR 0.131864 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -43.30% | 1.06M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
REMEDENT, INC. 
